Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Safran
  6. News
  7. Summary
    SAF   FR0000073272

SAFRAN

(SAF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European shares suffer worst day in 17 months on virus fears

11/26/2021 | 12:15pm EST
FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt

(Reuters) - European stocks plummeted amid widespread selling on Friday, as reports of a newly identified and possibly vaccine-resistant coronavirus variant stoked fears of a fresh hit to the global economy and drove investors out of riskier assets.

The benchmark STOXX 600 index ended 3.7% down in its worst session since June 2020, while the volatility gauge for the main stock market hit a near 10-month high.

The day's losses saw the STOXX 600 lose 4.5% this week.

Little is known of the variant detected in South Africa, Botswana and Hong Kong, but scientists said it has an unusual combination of mutations and may be able to evade immune responses or make it more transmissible.

France's CAC 40 shed 4.8%. UK's FTSE 100 dropped 3.6%, while Germany's DAX fell 4.2% and Spain's IBEX lost 5.0%.

"With Europe and some northern parts of the U.S. in a stretched situation due to an already high number of new cases and hospitalisations, this new virus strain comes at the worst possible time," said Peter Garnry, head of equity strategy at Saxo Bank.

"Equities are reacting negatively because it is unknown at this point to what degree the vaccines will be effective against the new strain, and thus it increases risk of new lockdowns."

Among the European stock sectors, travel and leisure plummeted 8.8% in its worst day since the COVID-19 shock sell-off in March 2020.

Britain announced a temporary ban on flights from South Africa and several neighbouring countries from 1200 GMT on Friday. The European Union is also planning similar moves.

Travel stocks were the worst performers this week, down 13.6%. Concerns over rising COVID-19 cases had pulled European stock markets from record highs last week amid fears of more restrictions.

The virus scare prompted euro zone money markets to scale back bets of a rate hike from the European Central Bank next year. Odds of a 10 basis point rate hike in December 2022 almost halved from 100% earlier this week.

Euro zone government bond yields dropped, pressuring European bank stocks, which lost 6.9%.

Oil & gas producers slumped 5.8%, while miners tumbled 5.0% as oil and metal prices lost ground as reports of the new virus variant fuelled economic slowdown worries. [O/R] [MET/L]

The technology sector had relatively smaller losses, thanks to gains in stay-at-home stocks. Defensives such as healthcare and utilities fell the least.

(Reporting by Sruthi Shankar and Bansari Mayur Kamdar in Bengaluru; Editing by Subhranshu Sahu, Arun Koyyur and Emelia Sithole-Matarise)

By Sruthi Shankar and Ambar Warrick


© Reuters 2021
All news about SAFRAN
10:17aSafran to provide engines and other equipment on H160M and H160 helicopters for the Fre..
AQ
09:33aSAFRAN : Barclays sticks Neutral
MD
01/14SAFRAN : Berenberg remains its Buy rating
MD
01/13SAFRAN : to provide engines and other equipment on H160M and H160 helicopters for the Fren..
PU
01/13SAFRAN : JP Morgan keeps its Buy rating
MD
01/13Airbus Renews Engineering Services Contract With Safran Engineering Services, Sonovisio..
MT
01/12SAFRAN : Bilan semestriel (31 décembre 2021) du contrat de liquidité (french only)
PU
01/12SAFRAN : Bilan semestriel (30 juin 2021) du contrat de liquidité (french only)
PU
01/07Airbus 2021 deliveries hover between 605 and 611 units -sources
RE
01/05SAFRAN : JP Morgan remains its Buy rating
MD
More news
Analyst Recommendations on SAFRAN
More recommendations
Financials
Sales 2021 15 529 M 17 711 M 17 711 M
Net income 2021 1 000 M 1 141 M 1 141 M
Net Debt 2021 1 657 M 1 890 M 1 890 M
P/E ratio 2021 48,0x
Yield 2021 0,85%
Capitalization 47 980 M 54 734 M 54 721 M
EV / Sales 2021 3,20x
EV / Sales 2022 2,62x
Nbr of Employees 78 900
Free-Float -
Chart SAFRAN
Duration : Period :
Safran Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SAFRAN
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 112,56 €
Average target price 131,69 €
Spread / Average Target 17,0%
EPS Revisions
Managers and Directors
Olivier Andriès Chief Executive Officer & Director
Pascal Joel Jacky Bantegnie Chief Financial Officer
Ross McInnes Chairman
Frédéric Verger Executive VP, Chief Digital & Information Officer
Eric Dalbies Senior VP-Research, Technology & Innovation
Sector and Competitors